BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Topics
»
Disease categories and therapies
» Ocular
Ocular
RSS
Allergan obtains rights to compound for PDT of age-related macular degeneration
Jan. 19, 2001
FDA approves study of KeraVision's Intacs inserts trial
Jan. 15, 2001
Aurora Biosciences and Allergan establish ion channel discovery collaboration
Jan. 15, 2001
Inspire's agent for dry eye enters phase III evaluation
Jan. 11, 2001
Prostaglandin analogues for glaucoma, ocular hypertension described in December patent
Dec. 22, 2000
CPMP recommends approval of Visudyne therapy for treatment of pathological myopia
Dec. 19, 2000
Allergan returns rBPI ophthalmic rights to Xoma
Nov. 20, 2000
Positive phase II results reported for INS-365 as dry eye disease treatment
Nov. 14, 2000
October launch for Rescula, a new docosanoid for glaucoma, in U.S.
Nov. 3, 2000
Allergan's novel glaucoma drug nears clinical trials
Nov. 2, 2000
Previous
1
2
…
359
360
361
362
363
364
365
366
367
…
398
399
Next
RSS